Geneva, Aug. 5 -- International Clinical Trials Registry received information related to the study (ACTRN12625000766415) titled 'Pregabalin (PRG) ophthalmic solutions in patients diagnosed with Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)' on July 18.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Tavo Biotherapeutics
Condition:
Primary Open-Angle Glaucoma (POAG)
Ocular Hypertension (OHT)
Primary Open-Angle Glaucoma (POAG)
Ocular Hypertension (OHT)
Eye - Diseases / disorders of the eye
Intervention:
This study is a Phase 1, randomized, single-masked, multiple ascending dose (MAD) study designed to evaluate the safety, tolerability, and prelim...